Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 16:14:1145551.
doi: 10.3389/fphar.2023.1145551. eCollection 2023.

Nanoparticle-based radiosensitization strategies for improving radiation therapy

Affiliations
Review

Nanoparticle-based radiosensitization strategies for improving radiation therapy

Hongxin Shen et al. Front Pharmacol. .

Abstract

Radiotherapy remains the mainstay treatment for a variety of cancer forms. However, the therapeutic efficiency of radiation is significantly limited by several aspects, including high radiation resistance caused by low reactive oxygen species concentrations and a low absorption rate of radiation by tumor tissue, inappropriate tumor cell cycle and tumor cell apoptosis, and serious radiation damage to normal cells. In recent years, nanoparticles have been widely used as radiosensitizers due to their unique physicochemical properties and multifunctionalities for potentially enhancing radiation therapy efficacy. In this study, we systematically reviewed several nanoparticle-based radiosensitization strategies for radiation therapy use, including designing nanoparticles that upregulate the levels of reactive oxygen species, designing nanoparticles that enhance the radiation dose deposit, designing chemical drug-loaded nanoparticles for enhancing cancer cell sensitivity to radiation, designing antisense oligonucleotide gene-loaded nanoparticles, and designing nanoparticles using a unique radiation-activable property. The current challenges and opportunities for nanoparticle-based radiosensitizers are also discussed.

Keywords: antisense oligonucleotide gene; chemical drugs; nanoparticle strategy; radiation dose deposit; radiation-activable property; radiosensitizers; radiotherapy; reactive oxygen species.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Barnett G. C., West C. M. L., Dunning A. M., Elliott R. M., Coles C. E., Pharoah P. D. P., et al. (2009). Normal tissue reactions to radiotherapy: Towards tailoring treatment dose by genotype. Nat. Rev.Cancer 9 (2), 134–142. 10.1038/nrc2587 - DOI - PMC - PubMed
    1. Bernier J., Hall E. J., Giaccia A. (2006). Radiation oncology: A century of achievements. Cancer. 4 (9), 737–747. 10.1038/nrc1451 - DOI - PubMed
    1. Brown J. M. (2007). Tumor hypoxia in cancer therapy. Methods Enzymol. 435, 297–321. 10.1016/S0076-6879(07)35015-5 - DOI - PubMed
    1. Chattopadhyay N., Cai Z., Kwon Y. L., Lechtman E., Pignol J. P., Reilly R. M. (2013). Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Breast Cancer Res. Treat. 137, 81–91. 10.1007/s10549-012-2338-4 - DOI - PubMed
    1. Choi J. W., Kim H.-C., Baek S. Y., Ryu Y. J., Chung J. W. (2015). A metastatic hepatoma model of rats using the 13762-MAT-B-III cell line: Basic characteristics and potential as a tool for interventional oncology experiments. Anticancer Res. 35 (3), 1333–1338. - PubMed

LinkOut - more resources